Prophylactic surgery for patients with longstanding ulcerative colitis.: Which option?: Histopathological and clinical implications

被引:4
|
作者
Willen, Roger [1 ]
Agnarsdottir, Margret [1 ]
Hulten, Leif [2 ]
机构
[1] Univ Uppsala Hosp, Ctr Lab Med, S-75185 Uppsala, Sweden
[2] Sahlgrens Univ Hosp, Inst Surg Sci, S-41685 Gothenburg, Sweden
关键词
INFLAMMATORY BOWEL-DISEASE; KOCK CONTINENT ILEOSTOMY; POUCH-ANAL ANASTOMOSIS; ILEORECTAL ANASTOMOSIS; CANCER RISK; RESTORATIVE PROCTOCOLECTOMY; ILEAL-POUCH; MUCOSAL ADAPTATION; ILEOANAL POUCH; PELVIC POUCH;
D O I
10.3109/2000-1967-094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with longstanding chronic ulcerative proctocolitis are at risk to develop colorectal cancer Conflicting views as regards surveillance, the indications for surgery and type of preventive procedure exist. For permanent prevention of cancer development complete removal of all potential malignant colorectal mucosa has to be done. Panprocto-colectomy with a conventional ileostomy or continent ileostomy removing all colorectal mucosa should therefore eliminate further risks of colorectal cancer. Colectomy and ileorectal anastomosis is a controversial issue. While many surgeons today are reluctant to use the technique, emphasising the persistent cancer risk, others consider the operation a viable alternative when used on a selective basis. The long-term risk of cancer in the rectal stump is the main strong argument. In restorative proctocolectomy, i.e. proctocolectomy with construction of an ileopouch anal anastomosis residual rectal mucosa is left behind irrespective of technique used and is therefore at risk for cancer development. Quite a few cancers have been reported to occur in these patients but controversy exists as regards the origin of these tumours but the risk for cancer development is very low. Biopsies from ileal pouches demonstrate various histopathological changes from nearly normal mucosa, to inflammation and atrophy, inflammatory cell changes, dysplasia as well as development of carcinoma. Grading of type and atypia is a challenge to reproduce and requires the participation of experienced gastrointestinal histopathologists.
引用
收藏
页码:49 / 60
页数:12
相关论文
共 50 条
  • [31] Which patients are at risk for clinical relapse in ulcerative colitis? A prospective study
    Boal Carvalho, P.
    Dias de Castro, F.
    Barbosa, M.
    Monteiro, S.
    Curdia Goncalves, T.
    Rosa, B.
    Moreira, M. J.
    Cotter, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S172 - S173
  • [32] Which Patients Are at Risk for Clinical Relapse in Ulcerative Colitis? A Prospective Study
    Carvalho, Pedro Boal
    de Castro, Francisca Dias
    Barbosa, Mara
    Monteiro, Sara
    Goncalves, Tiago Curdia
    Rosa, Bruno
    Moreira, Maria Joao
    Cotter, Jose
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S14 - S15
  • [33] Which Patients Are at Risk for Clinical Relapse in Ulcerative Colitis? A Prospective Study
    Boal Carvalho, Pedro
    Dias de Castro, Francisca
    Barbosa, Mara
    Monteiro, Sara
    Curdia Goncalves, Tiago
    Rosa, Bruno
    Joao Moreira, Maria
    Cotter, Jose
    GASTROENTEROLOGY, 2016, 150 (04) : S993 - S993
  • [34] Expression of chemokine genes in the colonic mucosa of patients with ulcerative colitis.
    Yang, SK
    Kim, OH
    Lee, MH
    Song, K
    Jung, HC
    Hong, WS
    Min, YL
    GASTROENTEROLOGY, 1997, 112 (04) : A1126 - A1126
  • [35] Longitudinal immune profiling of peripheral blood in patients with Ulcerative Colitis.
    Wider-Eberspaecher, E.
    Garza, A. P.
    Albrecht, T.
    Rosania, R.
    Dunay, I. R.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I452 - I452
  • [36] Quality of life (QOL) assessment in Korean patients with ulcerative colitis.
    Cho, YS
    Kim, WH
    Yoo, HM
    Moon, YM
    Kang, JK
    Park, IS
    Park, EC
    Lim, JG
    GASTROENTEROLOGY, 1999, 116 (04) : A681 - A681
  • [37] Immunomodulation with Ω-3 essential fatty acids in patients with ulcerative colitis.
    Varghese, TJ
    Coomansingh, D
    Richarson, S
    Brunt, PW
    Mowat, NA
    ElTahir, A
    Eremin, O
    GASTROENTEROLOGY, 2000, 118 (04) : A1375 - A1375
  • [38] Characteristic of mucosal polyamine content at rectum in patients with ulcerative colitis.
    Tsujikawa, T
    Fukuda, M
    Kimura, T
    Myojo, S
    Sakamoto, K
    Andoh, A
    Inoue, H
    Fujiyama, Y
    Bamba, T
    GASTROENTEROLOGY, 1997, 112 (04) : A1106 - A1106
  • [39] Contribution of HLA complex to the disease phenotype in patients with ulcerative colitis.
    Annese, V
    Lombardi, G
    Piepoli, A
    Latiano, A
    Bovio, P
    Napolitano, G
    Andriulli, A
    GASTROENTEROLOGY, 1998, 114 (04) : A920 - A920
  • [40] IMPACT OF PREOPERATIVE TACROLIMUS ON THE POSTOPERATIVE COURSE IN PATIENTS WITH ULCERATIVE COLITIS.
    Shimada, N.
    Ohge, H.
    Watadani, Y.
    Uegami, S.
    Shigemoto, N.
    Murao, N.
    Yano, R.
    Nakagawa, N.
    Kondo, N.
    Uemura, K.
    Murakami, Y.
    Sueda, T.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E171 - E171